Navigating the 2024 ESC Hypertension Guidelines: What Is New, Context, and Future Directions.
作者信息
Lu Yuan, Spatz Erica S, Krumholz Harlan M
出版信息
J Am Coll Cardiol. 2025 Feb 11;85(5):556-559. doi: 10.1016/j.jacc.2024.10.114. Epub 2025 Jan 2.
Abstract
摘要
相似文献
1
Navigating the 2024 ESC Hypertension Guidelines: What Is New, Context, and Future Directions.解读2024年欧洲心脏病学会高血压指南：新内容、背景及未来方向
J Am Coll Cardiol. 2025 Feb 11;85(5):556-559. doi: 10.1016/j.jacc.2024.10.114. Epub 2025 Jan 2.
2
Cardiovascular risk stratification according to the 2003 ESH-ESC guidelines in uncomplicated patients with essential hypertension: comparison with the 1999 WHO/ISH guidelines criteria.根据2003年欧洲高血压学会（ESH）和欧洲心脏病学会（ESC）指南对单纯原发性高血压患者进行心血管风险分层：与1999年世界卫生组织/国际高血压学会（WHO/ISH）指南标准的比较。
Blood Press. 2004;13(3):144-51. doi: 10.1080/08037050410033169.
3
Impact of 2018 ESC/ESH and 2017 ACC/AHA Hypertension Guidelines: Difference in Prevalence of White-Coat and Masked Hypertension.2018年欧洲心脏病学会/欧洲高血压学会及2017年美国心脏病学会/美国心脏协会高血压指南的影响：白大衣高血压和隐匿性高血压患病率的差异
Healthcare (Basel). 2020 May 3;8(2):122. doi: 10.3390/healthcare8020122.
4
Summary of 2018 ESC Guidelines on definition of myocardial infarction, myocardial revascularisation, cardiovascular disease during pregnancy and on arterial hypertension.2018 年 ESC 指南：心肌梗死、心肌血运重建、妊娠期间心血管疾病和动脉高血压定义摘要。
Acta Cardiol. 2020 Jun;75(3):179-185. doi: 10.1080/00015385.2019.1569315. Epub 2019 May 24.
5
Eligibility to treatment and economic effect of the implementation of the new U.S. or European Society of Hypertension/European Society of Cardiology hypertension guidelines.新的美国或欧洲高血压学会/欧洲心脏病学会高血压指南实施的治疗资格及经济效应
J Hypertens. 2015 Apr;33(4):868-73. doi: 10.1097/HJH.0000000000000466.
6
Impact of the European and American guidelines on hypertension prevalence, treatment, and cardiometabolic goals.欧美指南对高血压患病率、治疗和心血管代谢目标的影响。
J Hypertens. 2019 Jul;37(7):1393-1400. doi: 10.1097/HJH.0000000000002065.
7
[2018 update ESC/ESH guidelines on management of arterial hypertension : What is important for anesthesiologists?].[2018年欧洲心脏病学会/欧洲高血压学会动脉高血压管理指南更新：麻醉医师应关注哪些要点？]
Anaesthesist. 2019 May;68(5):325-328. doi: 10.1007/s00101-019-0576-0.
8
[Comments on the guidelines (2018) of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH) on the management of arterial hypertension].[关于欧洲心脏病学会（ESC）和欧洲高血压学会（ESH）2018年动脉高血压管理指南的评论]
Internist (Berl). 2019 Apr;60(4):424-430. doi: 10.1007/s00108-019-0576-9.
9
Blood pressure per the 2017 ACC/AHA and 2018 ESC/ESH guidelines and heart failure risk: the Suita Study.根据2017年美国心脏病学会/美国心脏协会和2018年欧洲心脏病学会/欧洲高血压学会指南的血压与心力衰竭风险：须惠研究
Hypertens Res. 2023 Mar;46(3):575-582. doi: 10.1038/s41440-022-01128-3. Epub 2023 Jan 6.
10
Screening for pulmonary arterial hypertension in patients with systemic sclerosis in the era of new pulmonary arterial hypertension definitions.在新肺动脉高压定义时代对系统性硬皮病患者进行肺动脉高压筛查。
Clin Exp Rheumatol. 2024 Aug;42(8):1590-1597. doi: 10.55563/clinexprheumatol/gzo4r2. Epub 2024 Mar 15.
本文引用的文献
1
Barriers to Optimal Clinician Guideline Adherence in Management of Markedly Elevated Blood Pressure: A Qualitative Study.显著高血压管理中临床医生遵循指南的障碍：定性研究。
JAMA Netw Open. 2024 Aug 1;7(8):e2426135. doi: 10.1001/jamanetworkopen.2024.26135.
2
Transforming Hypertension Diagnosis and Management in The Era of Artificial Intelligence: A 2023 National Heart, Lung, and Blood Institute (NHLBI) Workshop Report.人工智能时代的高血压诊断与管理变革：2023年美国国立心肺血液研究所（NHLBI）研讨会报告
Hypertension. 2025 Jan;82(1):36-45. doi: 10.1161/HYPERTENSIONAHA.124.22095. Epub 2024 Jul 16.
3
Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial.在伴有或不伴有糖尿病或既往卒中的心血管高危患者中，将收缩压降低至 120mmHg 以下与降低至 140mmHg 以下：一项开放标签、盲法结局、随机试验。
Lancet. 2024 Jul 20;404(10449):245-255. doi: 10.1016/S0140-6736(24)01028-6. Epub 2024 Jun 27.
4
Qualitative and Mixed Methods Research in Cardiovascular Care: Opportunities in the Coming Decades.心血管护理中的定性和混合方法研究：未来几十年的机遇。
Circ Cardiovasc Qual Outcomes. 2024 May;17(5):e010586. doi: 10.1161/CIRCOUTCOMES.124.010586. Epub 2024 May 21.
5
Digital Health Interventions for Hypertension Management in US Populations Experiencing Health Disparities: A Systematic Review and Meta-Analysis.数字健康干预措施在管理美国健康差异人群高血压中的应用：系统评价和荟萃分析。
JAMA Netw Open. 2024 Feb 5;7(2):e2356070. doi: 10.1001/jamanetworkopen.2023.56070.
6
Assessing and Addressing Social Determinants of Cardiovascular Health: JACC State-of-the-Art Review.评估和解决心血管健康的社会决定因素：JACC 最新观点综述。
J Am Coll Cardiol. 2023 Apr 11;81(14):1368-1385. doi: 10.1016/j.jacc.2023.01.042.
7
National Trends in Racial and Ethnic Disparities in Antihypertensive Medication Use and Blood Pressure Control Among Adults With Hypertension, 2011-2018.2011 年至 2018 年期间，高血压成年人中抗高血压药物使用和血压控制的种族和民族差异的国家趋势。
Hypertension. 2022 Jan;79(1):207-217. doi: 10.1161/HYPERTENSIONAHA.121.18381. Epub 2021 Nov 15.
8
Risk-Based Intensive Blood Pressure Lowering and Prevention of Heart Failure: A SPRINT Post Hoc Analysis.基于风险的强化降压与心力衰竭预防：SPRINT 事后分析。
Hypertension. 2021 Dec;78(6):1742-1749. doi: 10.1161/HYPERTENSIONAHA.121.18315. Epub 2021 Nov 1.
9
National Trends and Disparities in Hospitalization for Acute Hypertension Among Medicare Beneficiaries (1999-2019).医保受益人群中急性高血压住院治疗的全国趋势和差异（1999-2019 年）。
Circulation. 2021 Nov 23;144(21):1683-1693. doi: 10.1161/CIRCULATIONAHA.121.057056. Epub 2021 Nov 8.
10
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension.老年高血压患者强化血压控制试验。
N Engl J Med. 2021 Sep 30;385(14):1268-1279. doi: 10.1056/NEJMoa2111437. Epub 2021 Aug 30.
Zotero 插件